# reload+after+2024-01-19 23:43:06.434613
address1§44370 Old Warm Springs Boulevard
city§Fremont
state§CA
zip§94538
country§United States
phone§(510)-668-0881
website§https://www.abvcpharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.
fullTimeEmployees§19
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Eugene  Jiang', 'age': 37, 'title': 'Chairman & Chief Business Officer', 'yearBorn': 1986, 'fiscalYear': 2022, 'totalPay': 200000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Leeds  Chow', 'age': 34, 'title': 'CFO & Principal Accounting Officer', 'yearBorn': 1989, 'fiscalYear': 2022, 'totalPay': 130000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Tsung-Shann  Jiang EMBA, Ph.D.', 'age': 69, 'title': 'Chief Scientific Officer & Director', 'yearBorn': 1954, 'fiscalYear': 2022, 'totalPay': 200000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Uttam Yashwant Patil Ph.D.', 'age': 37, 'title': 'Chief Executive Officer', 'yearBorn': 1986, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.675
priceToSalesTrailing12Months§14.350921
currency§USD
dateShortInterest§1702598400
forwardEps§-0.44
exchange§NCM
quoteType§EQUITY
shortName§ABVC Biopharma, Inc.
longName§ABVC BioPharma, Inc.
firstTradeDateEpochUtc§1100097000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§0f8af6cd-1e3f-33ab-b7e9-bb4a28098e33
gmtOffSetMilliseconds§-18000000
recommendationMean§3.0
recommendationKey§hold
quickRatio§0.223
grossMargins§0.42071
ebitdaMargins§0.0
trailingPegRatio§None
